Study for the Treatment of Chronic Idiopathic Urticaria With High Doses of AERIUS (Desloratadine) (Study P04849)

Summary

This study will investigate the effectiveness of desloratadine at doses higher (10 mg and 20 mg) than currently approved (5 mg) for the treatment of chronic idiopathic urticaria. Subjects with chronic urticaria who are currently taking a second generation antihistamine will be treated with desloratadine (5, 10, or 20 mg) for 28 days.

Timeline

Start

2007-09

Primary completion

2009-04

Completion

2009-04

Outcome

Missed primary endpoint

registry analysis (unspecified test); 5-mg Desloratadine vs 20-mg Desloratadine; p = 0.721; ANCOVA NCT00536380 ↗

Drugs

Indications